Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Goodman

Showing results (921-930 of 1,119) with videos related to

Pageof 112
Sort By:
European Journal of Preventive Cardiology|March 19, 2024
Comparison of change in lipoprotein(a) mass and molar concentrations by alirocumab and risk of subsequent cardiovascular events in ODYSSEY OUTCOMESMichael Szarek, Esther Reijnders, Ph Gabriel Steg, et al.
BMC Genomics|December 2, 2017
The insect pathogenic bacterium Xenorhabdus innexi has attenuated virulence in multiple insect model hosts yet encodes a potent mosquitocidal toxinIl-Hwan Kim, Sudarshan K Aryal, Dariush T Aghai, et al.
Clinical Cardiology|November 4, 2020
Diabetes association with self-reported health, resource utilization, and prognosis post-myocardial infarctionJosé C Nicolau, David Brieger, Ruth Owen, et al.
Heart (British Cardiac Society)|July 16, 2015
Consistency of benefit from an early invasive strategy after fibrinolysis: a patient-level meta-analysisHusam Abdel-Qadir, Andrew T Yan, Mary Tan, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 25, 2012
Baseline characteristics of subjects enrolled in the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) trialGlenn M Chertow, Ricardo Correa-Rotter, Geoffrey A Block, et al.
European Journal of Preventive Cardiology|June 16, 2022
Achievement of ESC/EAS LDL-C treatment goals after an acute coronary syndrome with statin and alirocumabUlf Landmesser, Jennifer McGinniss, Ph Gabriel Steg, et al.
International Journal of Cardiology|May 31, 2016
Temporal trends in all-cause mortality according to smoking status: Insights from the Global Registry of Acute Coronary EventsYaron Arbel, Gordon FitzGerald, Andrew T Yan, et al.
Bioengineering & Translational Medicine|December 17, 2016
Reducing neuroinflammation by delivery of IL-10 encoding lentivirus from multiple-channel bridgesDaniel J Margul, Jonghyuck Park, Ryan M Boehler, et al.
The Canadian Journal of Cardiology|May 27, 2018
Long-term Follow-up of the Trial of Routine Angioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI)Yaron Arbel, Dennis T Ko, Andrew T Yan, et al.
American Heart Journal|December 3, 2014
Routine invasive management early after fibrinolysis: relationship between baseline risk and treatment effects in a pooled patient-level analysis of 7 randomized controlled trialsAkshay Bagai, Mary Tan, Carlo Di Mario, et al.
Pageof 112

Showing results (921-930 of 1,119) with videos related to

Sort By:
Pageof 112
European Journal of Preventive Cardiology|March 19, 2024
Comparison of change in lipoprotein(a) mass and molar concentrations by alirocumab and risk of subsequent cardiovascular events in ODYSSEY OUTCOMESMichael Szarek, Esther Reijnders, Ph Gabriel Steg, et al.
BMC Genomics|December 2, 2017
The insect pathogenic bacterium Xenorhabdus innexi has attenuated virulence in multiple insect model hosts yet encodes a potent mosquitocidal toxinIl-Hwan Kim, Sudarshan K Aryal, Dariush T Aghai, et al.
Clinical Cardiology|November 4, 2020
Diabetes association with self-reported health, resource utilization, and prognosis post-myocardial infarctionJosé C Nicolau, David Brieger, Ruth Owen, et al.
Heart (British Cardiac Society)|July 16, 2015
Consistency of benefit from an early invasive strategy after fibrinolysis: a patient-level meta-analysisHusam Abdel-Qadir, Andrew T Yan, Mary Tan, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 25, 2012
Baseline characteristics of subjects enrolled in the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) trialGlenn M Chertow, Ricardo Correa-Rotter, Geoffrey A Block, et al.
European Journal of Preventive Cardiology|June 16, 2022
Achievement of ESC/EAS LDL-C treatment goals after an acute coronary syndrome with statin and alirocumabUlf Landmesser, Jennifer McGinniss, Ph Gabriel Steg, et al.
International Journal of Cardiology|May 31, 2016
Temporal trends in all-cause mortality according to smoking status: Insights from the Global Registry of Acute Coronary EventsYaron Arbel, Gordon FitzGerald, Andrew T Yan, et al.
Bioengineering & Translational Medicine|December 17, 2016
Reducing neuroinflammation by delivery of IL-10 encoding lentivirus from multiple-channel bridgesDaniel J Margul, Jonghyuck Park, Ryan M Boehler, et al.
The Canadian Journal of Cardiology|May 27, 2018
Long-term Follow-up of the Trial of Routine Angioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI)Yaron Arbel, Dennis T Ko, Andrew T Yan, et al.
American Heart Journal|December 3, 2014
Routine invasive management early after fibrinolysis: relationship between baseline risk and treatment effects in a pooled patient-level analysis of 7 randomized controlled trialsAkshay Bagai, Mary Tan, Carlo Di Mario, et al.
Pageof 112